Raymond James analyst Patrick O’Shaughnessy maintains S&P Global (NYSE:SPGI) with a Outperform and raises the price target from $398 to $402.
Here’s How Much $100 Invested In West Pharmaceutical Servs 15 Years Ago Would Be Worth Today
West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 15 years by 9.84% on an annualized…